United States · Funded startup

Who invested in Provention Bio

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$63Mraised across 2 rounds since 2017, from 2 sources

$28MSeries B$35MRound

Latest round: Round, $35MFeb 2023
Step-upi: 1.2×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201820192020202120222023

$28MSeries B$35MRound

First round: Series B, $28M
Biggest round: $35M
Between rounds: 5.6 years

The rounds

Feb 2023
Round$35M3 new
Source recorded
Jun 2017
Series B$28M
No investor was named in the report.
Reported by FinSMEsSEC filing: $28M sold, first sale Apr 2017

Founders and team

From the SEC filings it signed: 1 on the team.

Ashleigh PalmerExecutive Officer, Directori

On the board, as filediAnthony DiGiandomenicoCameron GrayFrancisco Leon

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2017Round2023

B Capital

Sanofi

Hercules Capital

Everyone who backed them

B CapitalVC firm1round

SanofiInvestment firm1round

Hercules CapitalVenture debt1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Provention Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.